Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cynosure Inc (NASDAQ:CYNO)

53.83
Delayed Data
As of Jul 28
 -0.09 / -0.17%
Today’s Change
29.00
Today|||52-Week Range
55.94
+20.51%
Year-to-Date
Illumina (ILMN) Beats Q2 Earnings, Revenues; EPS View Up
Jul 27 / Zacks.com - Paid Partner Content
Cynosure (CYNO) Reaches New Lifetime High Today
Jul 26 / TheStreet.com - Paid Partner Content
Edwards Lifesciences (EW) Tops Q2 Earnings, '16 View Up
Jul 27 / Zacks.com - Paid Partner Content
Med-Instrument Stocks to Post Earnings: EW, CYNO, GMED
Jul 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close53.92
Today’s open53.56
Day’s range53.56 - 54.25
Volume223,063
Average volume (3 months)343,157
Market cap$1.3B
Dividend yield--
Data as of 07/28/2016

Growth & Valuation

Earnings growth (last year)-50.35%
Earnings growth (this year)+24.23%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+16.11%
P/E ratio66.4
Price/Sales2.98
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc-0.52-1.51%
CNMDConmed Corp-8.28-17.18%
PCRXPacira Pharmaceutica...+0.57+1.54%
PTLAPortola Pharmaceutic...-0.01-0.04%
Data as of 07/28/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$339.5M
Annual profit (last year)$15.8M
Net profit margin4.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Davin
Chief Operating &
Financial Officer
Timothy W. Baker
Corporate headquarters
Westford, Massachusetts

Forecasts

Partner Offers

Search for Jobs